229 related articles for article (PubMed ID: 33769773)
1. Utility of the Human Papillomavirus Vaccination in Management of HPV-associated Cutaneous Lesions.
Gay J; Johnson N; Kavuru V; Phillips M
Skin Therapy Lett; 2021 Mar; 26(2):6-8. PubMed ID: 33769773
[TBL] [Abstract][Full Text] [Related]
2. Nonavalent human papillomavirus vaccination as alternative treatment for genital warts.
Bossart S; Gabutti MP; Seyed Jafari SM; Hunger RE
Dermatol Ther; 2020 Jul; 33(4):e13771. PubMed ID: 32500585
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
4. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL; Joura EA
BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
[TBL] [Abstract][Full Text] [Related]
5. [HPV vaccination with quadrivalent or nonavalent vaccine: an opportunity to eliminate genital warts as well].
van Bergen JEAM
Ned Tijdschr Geneeskd; 2020 Jan; 164():. PubMed ID: 32073799
[TBL] [Abstract][Full Text] [Related]
6. Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51.
Yadav R; Zhai L; Kunda NK; Muttil P; Tumban E
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200586
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
[TBL] [Abstract][Full Text] [Related]
8. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
9. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
Malinova M
Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
[TBL] [Abstract][Full Text] [Related]
10. Impact of HPV immunization on the detection of cervical disease.
Munro AJ; Cruickshank ME
Expert Rev Vaccines; 2014 Apr; 13(4):533-44. PubMed ID: 24606579
[TBL] [Abstract][Full Text] [Related]
11. HPV vaccines to prevent cervical cancer and genital warts: an update.
Dochez C; Bogers JJ; Verhelst R; Rees H
Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637
[TBL] [Abstract][Full Text] [Related]
12. [Research progression of prophylactic HPV vaccine application].
Zhang L; Zhao FH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):724-728. PubMed ID: 30392335
[TBL] [Abstract][Full Text] [Related]
13. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
Stanley M
Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
[TBL] [Abstract][Full Text] [Related]
14. [HPV vaccination and the prevention of genital warts and precancerous lesions-current evidence and evaluation].
Osmani V; Klug SJ
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 May; 64(5):590-599. PubMed ID: 33851224
[TBL] [Abstract][Full Text] [Related]
15. Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis.
Husein-ElAhmed H
Int J STD AIDS; 2020 Jun; 31(7):606-612. PubMed ID: 32438856
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccines and vaccine implementation.
de Sanjosé S; Alemany L; Castellsagué X; Bosch FX
Womens Health (Lond); 2008 Nov; 4(6):595-604. PubMed ID: 19072462
[TBL] [Abstract][Full Text] [Related]
17. The incidence of genital warts in Australian women prior to the national vaccination program.
Brotherton JM; Heywood A; Heley S
Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
[TBL] [Abstract][Full Text] [Related]
18. [The vaccines anti-HPV today in the treatment of the genital infections to HPV].
Gondry J
Ann Dermatol Venereol; 2017 Dec; 144(12S):S9-S10. PubMed ID: 29108875
[No Abstract] [Full Text] [Related]
19. Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.
Petry KU; Bollaerts K; Bonanni P; Stanley M; Drury R; Joura E; Kjaer SK; Meijer CJLM; Riethmuller D; Soubeyrand B; Van Damme P; Bosch X
Hum Vaccin Immunother; 2018 Jul; 14(7):1800-1806. PubMed ID: 29553886
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the power of prevention: human papillomavirus vaccines.
Mayeaux EJ
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]